NEWS
- From ADC to XDC: Types of Novel Drug Conjugates
- Next-Generation PDC: Linker Design with PEG & Clinical Progress
- Oral Macrocyclic Peptides in Clinical Practice
- Meet Us at TIDES USA 2026, Booth #826
- FDA 2025 Approvals: Innovation and Next-Gen Blockbuster Drugs
- 2026 FDA Drug Approvals: Blockbusters to Watch
- The Rise of PD-L1 ADCs: A New Paradigm in Cancer Therapy
- Overview of HER2-targeted Drugs
- Molecular Glues: A New Dawn After PROTAC
- Overview of ADC-Based Combination Therapies
